{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T13:23:08Z","timestamp":1700572988353},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s11886-008-0063-8","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T07:07:21Z","timestamp":1224054441000},"page":"402-406","source":"Crossref","is-referenced-by-count":6,"title":["The risks and benefits of drug-eluting stents in the setting of STEMI"],"prefix":"10.1007","volume":"10","author":[{"given":"Rosetta","family":"Melfi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annunziata","family":"Nusca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Patti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germano","family":"Di Sciascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,16]]},"reference":[{"key":"63_CR1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","volume":"361","author":"E.C. Keeley","year":"2003","unstructured":"Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003, 361:13\u201320.","journal-title":"Lancet"},{"key":"63_CR2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"J.W. Moses","year":"2003","unstructured":"Moses JW, Leon MB, Popma JJ, et al.: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003, 349:1315\u20131323.","journal-title":"N Engl J Med"},{"key":"63_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"G.W. Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA, et al.: A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004, 350:221\u2013231.","journal-title":"N Engl J Med"},{"key":"63_CR4","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2007.06.029","volume":"50","author":"M.C. Morice","year":"2007","unstructured":"Morice MC, Serruys PW, Barragan P, et al.: Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial. J Am Coll Cardiol 2007, 50:1299\u20131304.","journal-title":"J Am Coll Cardiol"},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","volume":"346","author":"G.W. Stone","year":"2002","unstructured":"Stone GW, Grines CL, Cox DA, et al.: Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. N Engl J Med 2002, 346:957\u2013966.","journal-title":"N Engl J Med"},{"key":"63_CR6","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.297.18.2001","volume":"297","author":"H.K. Win","year":"2007","unstructured":"Win HK, Caldera AE, Maresh K, et al.: Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007, 297:2001\u20132009.","journal-title":"JAMA"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ccd.21093","volume":"69","author":"J.M. Hodgson","year":"2007","unstructured":"Hodgson JM, Stone GW, Lincoff AM, et al.: Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force. Catheter Cardiovasc Interv 2007, 69:327\u2013333.","journal-title":"Catheter Cardiovasc Interv"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","volume":"48","author":"M. Pfisterer","year":"2006","unstructured":"Pfisterer M, Brunner-La Rocca HB, Buser PT, et al.: Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting stents versus bare metal stents. J Am Coll Cardiol 2006, 48:2584\u20132591.","journal-title":"J Am Coll Cardiol"},{"key":"63_CR9","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/CIRCULATIONAHA.105.600155","volume":"113","author":"P.K. Kuchulakanti","year":"2006","unstructured":"Kuchulakanti PK, Chu WW, Torguson R, et al.: Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents. Circulation 2006, 113:1108\u20131113.","journal-title":"Circulation"},{"key":"63_CR10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/hrt.2003.026047","volume":"90","author":"F. Alfonso","year":"2004","unstructured":"Alfonso F, Su\u00e1rez A, Angiolillo DJ, et al.: Findings of intravascular ultrasound during acute stent thrombosis. Heart 2004, 90:1455\u20131459.","journal-title":"Heart"},{"key":"63_CR11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/eurheartj\/ehi135","volume":"26","author":"P. Wenaweser","year":"2005","unstructured":"Wenaweser P, Rey C, Eberli FR, et al.: Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J 2005, 26:1180\u20131187.","journal-title":"Eur Heart J"},{"key":"63_CR12","first-page":"3","volume":"45","author":"C. Borna","year":"2005","unstructured":"Borna C, Lazarowski E, van Heusden C, et al.: Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J 2005, 45:3\u201310.","journal-title":"Thromb J"},{"key":"63_CR13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCULATIONAHA.105.563403","volume":"113","author":"M.K. Hong","year":"2006","unstructured":"Hong MK, Mintz GS, Lee CW, et al.: Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006, 113:414\u2013419.","journal-title":"Circulation"},{"key":"63_CR14","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/jama.293.17.2109","volume":"293","author":"M. Valgimigli","year":"2005","unstructured":"Valgimigli M, Percoco G, Malagutti P, et al.: Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 2005, 293:2109\u20132117.","journal-title":"JAMA"},{"key":"63_CR15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jacc.2007.04.059","volume":"50","author":"G. Sianos","year":"2007","unstructured":"Sianos G, Papafaklis MI, Daemen J, et al.: Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol 2007, 50:573\u2013583.","journal-title":"J Am Coll Cardiol"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.amjcard.2005.11.054","volume":"97","author":"M.C. Newell","year":"2006","unstructured":"Newell MC, Henry CR, Sigakis CJ, et al.: Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2006, 97:1299\u20131302.","journal-title":"Am J Cardiol"},{"key":"63_CR17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ccd.20395","volume":"65","author":"E. Cheneau","year":"2005","unstructured":"Cheneau E, Rha SW, Kuchulakanti PK, et al.: Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty. Catheter Cardiovasc Interv 2005, 65:469\u2013472.","journal-title":"Catheter Cardiovasc Interv"},{"key":"63_CR18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacc.2003.12.022","volume":"43","author":"P.A. Lemos","year":"2004","unstructured":"Lemos PA, Saia F, Hofma SH, et al.: Short-and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004, 43:704\u2013708.","journal-title":"J Am Coll Cardiol"},{"key":"63_CR19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.amjcard.2006.11.070","volume":"99","author":"J. Daemen","year":"2007","unstructured":"Daemen J, Tanimoto S, Garc\u00eda-Garc\u00eda HM, et al.: Comparison of three-year clinical outcome of sirolimus-and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 2007, 99:1027\u20131032.","journal-title":"Am J Cardiol"},{"issue":"Suppl6A","key":"63_CR20","first-page":"1L","volume":"92","author":"V. Pasceri","year":"2003","unstructured":"Pasceri V, Granatelli A, Pristipino C, et al.: A randomized clinical trial of a rapamycin-eluting stent in acute myocardial infarction: preliminary results. TCT 2003. Am J Cardiol 2003, 92(Suppl 6A):1L.","journal-title":"Am J Cardiol"},{"key":"63_CR21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa062598","volume":"355","author":"G.J. Laarman","year":"2006","unstructured":"Laarman GJ, Suttorp MJ, Dirksen MT, et al.: Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006, 355:1105\u20131113.","journal-title":"N Engl J Med"},{"key":"63_CR22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa062006","volume":"355","author":"C. Spaulding","year":"2006","unstructured":"Spaulding C, Henry P, Teiger E, et al.: Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006, 355:1093\u20131104.","journal-title":"N Engl J Med"},{"key":"63_CR23","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jacc.2007.01.081","volume":"49","author":"M. Menichelli","year":"2007","unstructured":"Menichelli M, Parma A, Pucci E, et al.: Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol 2007, 49:1924\u20131930.","journal-title":"J Am Coll Cardiol"},{"key":"63_CR24","unstructured":"Tierala I: Helsinki Area Acute Myocardial Infarction Treatment Re-Evaluation-Should the Patients Get a Drug-Eluting or Normal Stent (HAAMU-STENT). Presented at the Transcatheter Cardiovascular Therapeutics meeting (TCT 2006). Washington, DC; October 2006. http:\/\/www.cardiosource.com . Accessed March 1, 2008."},{"key":"63_CR25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacc.2007.09.056","volume":"51","author":"B.L. Hoeven van der","year":"2008","unstructured":"van der Hoeven BL, Liem SS, Jukema JW, et al.: Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study. J Am Coll Cardiol 2008, 51:618\u2013626.","journal-title":"J Am Coll Cardiol"},{"key":"63_CR26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ahj.2007.02.016","volume":"153","author":"V. Pasceri","year":"2007","unstructured":"Pasceri V, Patti G, Speciale G, et al.: Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 2007, 153:749\u2013754.","journal-title":"Am Heart J"},{"key":"63_CR27","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehm402","volume":"28","author":"A. Kastrati","year":"2007","unstructured":"Kastrati A, Dibra A, Spaulding C, et al.: Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 2007, 28:2706\u20132713.","journal-title":"Eur Heart J"},{"key":"63_CR28","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I. Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, et al.: Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005, 293:2126\u20132130.","journal-title":"JAMA"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-008-0063-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-008-0063-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-008-0063-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:09Z","timestamp":1559433369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-008-0063-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s11886-008-0063-8","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}